Immuno-Augmentation With GM-CSF in Patients Receiving Pneumococcal Vaccine While Undergoing Treatment for Advanced Chronic Lymphocytic Leukemia (CLL).
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2012
At a glance
- Drugs Sargramostim (Primary) ; Pneumococcal vaccine
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 21 Nov 2009 Planned number of patients changed from 64 to 87 as reported by M.D. Anderson Cancer Center.
- 01 Apr 2009 New source identified and integrated (M.D. Anderson Cancer Center 2003-0605).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History